Inflammatory chorioretinopathies Flashcards
?
- Birdshot: Age 30-70 (older); F>M, Bilateral, 80-98% are HLA A29 positive. Insiduous onset, chronic, recurrent. Prognosis guarded without treatment. Therapy: systemic/local steroids; IMT.
Birdshot Symptoms
- Blurred vision, floaters, photopsias, disturbed color / night vision.
Birdshot Exam
- vitritis, ovoid creamy white-yellow post-equatorial lesions
Birdshot Complications
vasculitis, disc edema, CME, CNV (6%)
Birdshot FA
early hypofluorescence, late stain, leakage from disk, CNVM
Birdshot ICG
hypofluorescent lesions more numerous than on exam
Birdshot FAF
hypoautofluourescent lesions more numerous than clinically apparent; placoid macular hypoautofluoresence with central vision loss
Birdshot OCT
ME, loss of IS/OS, suprachoroidal fluid
Birdshot ERG
abnormal rod/cone response
?
- APMPPE: Age 20-50 (young). M=F. Bilateral. Viral prodrome, cerebrovasculitis, CSF abnormalities. Course is acute and self-limited. Visual prognosis is good. Therapy is observation; steroids if CNS involvement.
?
- Serpiginous Chorioretinitis: Age 20-60 (young-middle). M=F. Bilateral but asymmetric. Systemic association HLA B7. Rule out TB. Onset/course is variable and self-limited. Visual prognosis is guarded. Therapy is systemic/ local steroids and IMT. Anti-VEGF w/wo laser for CNVM.
?
- Age 9-69 (usually more young). F>M (3:1). Bilateral. Onset/course is insidious, . chronic/recurrent. Visual prognosis: guarded. Treatment: steroids, IMT. Anti-VEGF, +/- laser for CNVM.
?
PIC: age 18-40 (young). F (90%); bilateral. Onset/course is acute/self-limited. Prognosis is good if no CNVM. Treatment is systemic/local steroids, IMT, antivegf +/- laser
?
SFU: subretinal fibrosis and uveitis syndrome. Age 14-34 (Young). F>M (>95%). Asymmetric. Insidious, chronic, recurrent. Prognosis is guarded. Treatment is steroids for CME if present
?
- MEWDS: young (10-47); F (3:1), unilateral. Assc’n with viral prodrome in 50%. Course is acute, self limited. Prognosis is excellent. No treatment, just observation.
?
- ARPE: young (16-40). M=F. Unilateral (75%). No associated systemic issues. Acute self-limited. Prognosis is excellent. No treatment.
?
AZOOR: young. (13-63). F (3:1). Unilateral 24% of the time, bilateral 76% of the time. Associated with systemic autoimmune disease 28% of the time. Insiduous, chronic, recurrent (31% of the time). Prognosis is guarded. Treatment is steroids, IMT +/- antivirals
APMPPE symptoms
blurred vision, scotomata, photopsias
APMPPE exam
multifocal flat gray-white lesions 1-2 DD, RPE with evolving pigment
APMPPE complications
disc edema, pigmentary changes
APMPPE FA
acute lesions, early blockage, late staining, late window defects
APMPPE ICG:
hypofluorescent spots
APMPPE FAF
- hyperfluourscent areas corresponding to FA blockage and hypofluorescent areas corresponding to staining.
APMPPE OCT
outer retinal hyper-reflectivity with intra retinal and subretinal fluid
Serpiginous symptoms
blurred vision, scotomata